Alpha-Synuclein Lowering and Rescue of Motor Phenotype by miRNA-Based AAV Gene Therapy in In Vivo Parkinson's Disease Models

Seyda Acar Broekmans; Carlos Vendrell Tornero; Lodewijk Toonen; Mercedes Valls; Rhode Erbrink; Kaila E. Ronde; Wytse Hogewerf; Lisette E. D. Tolsma; Renee I. Seinstra; Leen L. S. Janssen; Ellen A. A. Nollen; Astrid Valles

Alpha-Synuclein Lowering and Rescue of Motor Phenotype by miRNA-Based AAV Gene Therapy in In Vivo Parkinson's Disease Models

Seyda Acar Broekmans, Carlos Vendrell Tornero, Lodewijk Toonen, Mercedes Valls, Rhode Erbrink, Kaila E. Ronde, Wytse Hogewerf, Lisette E. D. Tolsma, Renee I. Seinstra, Leen L. S. Janssen, Ellen A. A. Nollen, Astrid Valles

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	10-10
Aantal pagina's	1
Tijdschrift	Molecular Therapy
Volume	30
Nummer van het tijdschrift	4
Status	Published - apr.-2022

Handle.net

Permanente koppeling

Citeer dit

@article{6748ce0b43154526bb79537abce40ffb,

title = "Alpha-Synuclein Lowering and Rescue of Motor Phenotype by miRNA-Based AAV Gene Therapy in In Vivo Parkinson's Disease Models",

author = "Broekmans, {Seyda Acar} and Tornero, {Carlos Vendrell} and Lodewijk Toonen and Mercedes Valls and Rhode Erbrink and Ronde, {Kaila E.} and Wytse Hogewerf and Tolsma, {Lisette E. D.} and Seinstra, {Renee I.} and Janssen, {Leen L. S.} and Nollen, {Ellen A. A.} and Astrid Valles",

year = "2022",

month = apr,

language = "English",

volume = "30",

pages = "10--10",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Alpha-Synuclein Lowering and Rescue of Motor Phenotype by miRNA-Based AAV Gene Therapy in In Vivo Parkinson's Disease Models

AU - Broekmans, Seyda Acar

AU - Tornero, Carlos Vendrell

AU - Toonen, Lodewijk

AU - Valls, Mercedes

AU - Erbrink, Rhode

AU - Ronde, Kaila E.

AU - Hogewerf, Wytse

AU - Tolsma, Lisette E. D.

AU - Seinstra, Renee I.

AU - Janssen, Leen L. S.

AU - Nollen, Ellen A. A.

AU - Valles, Astrid

PY - 2022/4

Y1 - 2022/4

M3 - Meeting Abstract

SN - 1525-0016

VL - 30

SP - 10

EP - 10

JO - Molecular Therapy

JF - Molecular Therapy

IS - 4

ER -